Kodiak Sciences (KOD) EPS (Basic) (2017 - 2026)
Kodiak Sciences' (KOD) quarterly EPS (Basic) came in at -$8.45 in Q1 2026, down 650.52% YoY from $1.53 in Q1 2025, and down 16.75% on a QoQ basis from -$7.24 in Q4 2025.
Analysis
Kodiak Sciences (KOD) EPS (Basic) (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of EPS (Basic) data on file, last reported at -$8.45 in Q1 2026.
- Quarterly EPS (Basic) fell 650.52% year-over-year to -$8.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.33 (down 422.66% YoY) and the FY2025 annual result came in at -$10.49, down 30.43% from the prior year.
- EPS (Basic) declined to -$8.45 in Q1 2026, from -$7.24 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.85 in Q1 2024 to a low of -$8.45 in Q1 2026.
- A 5-year average of -$2.23 and a median of -$1.42 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 84.48% — and 2025, when it slumped 746.41%.
- Tracing KOD's EPS (Basic) over 5 years: stood at -$1.36 in 2022, then slipped by 4.69% to -$1.42 in 2023, then jumped by 39.96% to -$0.85 in 2024, then tumbled by 746.41% to -$7.24 in 2025, then retreated by 16.75% to -$8.45 in 2026.
- The last three EPS (Basic) figures came in at -$8.45 (Q1 2026), -$7.24 (Q4 2025), and -$4.31 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | -1.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 |
| Mar 31, 2026 | -0.94 |
| Dec 31, 2025 | -1.07 |
| Sep 30, 2025 | -1.16 |
| Jun 30, 2025 | -1.03 |
| Mar 31, 2025 | -1.09 |
| Dec 31, 2024 | -0.84 |
| Sep 30, 2024 | -0.83 |
| Jun 30, 2024 | -0.86 |
| Mar 31, 2024 | -0.81 |
| Dec 31, 2023 | -1.13 |
| Sep 30, 2023 | -0.95 |
| Jun 30, 2023 | -1.53 |
| Mar 31, 2023 | -1.36 |
| Dec 31, 2022 | -1.36 |
| Sep 30, 2022 | -1.47 |
| Jun 30, 2022 | -1.73 |
| Mar 31, 2022 | -1.83 |
| Dec 31, 2021 | -1.80 |
| Sep 30, 2021 | -1.30 |